Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Assura says PHP offer due diligence still ongoing

(Sharecast News) - Healthcare property investment and management firm Assura has confirmed that due diligence in relation to a takeover proposal from Primary Health Properties is still ongoing, with both parties "working closely" together. Due diligence in relation to PHP's 51.7p-a-share offer has been taking place over the past two weeks, and reciprocal due diligence "remains ongoing".

"The provision of due diligence materials continues and Assura is working closely with PHP to ensure that the process moves forward in a timely manner," the company said.

Assura had previously warmed to a 49.4p-a-share offer from KKR and Stonepeak, originally proposed on 9 April; though PHP re-entered the bidding war on 16 May with a sweetened bid, after having an earlier proposal been rejected.

The company then said on 23 May that had it intended to put off a court meeting and general meeting required to implement the initial offer from KKR and Stonepeak, together known as Sana Bido.

"Assura confirms that, on 5 June 2025, the meetings were formally adjourned until further notice," the company said on Friday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.